Morphine enhances Tat-induced activation in murine microglia. - Wikidata - awgldk - TriplyDB

Morphine enhances Tat-induced activation in murine microglia.

Morphine enhances Tat-induced activation in murine microglia.

http://www.wikidata.org/entity/Q35063629

about

Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease HIV, opiates, and enteric neuron dysfunction A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neurites Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration.Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV neuropathogenesis: a tight rope walk of innate immunity.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycle Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.Morphine potentiates neuropathogenesis of SIV infection in rhesus macaques Disruption of gut homeostasis by opioids accelerates HIV disease progression Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.Toll-like receptors in chronic pain.Morphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophages Morphine activates neuroinflammation in a manner parallel to endotoxin Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder.Cocaine-mediated induction of microglial activation involves the ER stress-TLR2 axis Mechanism(s) involved in opioid drug abuse modulation of HAND Morphine exposure during HIV encephalitis in SCID mice.Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions.Substance abuse, HIV-1 and hepatitis Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.Fate of microglia during HIV-1 infection: From activation to senescence?HIV, Tat and dopamine transmission.GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling.HIV-associated synaptic degeneration.Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure.HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter.

P2860

Q26746336-54CEACB5-2478-465D-A9A1-CA25EF8AF82E Q26770397-56EF188B-8AF8-4E9D-AEFC-2EE4C86C5AB3 Q27023420-A8035079-48F0-497B-A24D-6FA88501483D Q28477511-8028FF34-31AE-4D8A-9B32-EF138C4ABCFB Q28478866-E653F06F-E19B-4BE3-A539-476FFBC6E95B Q28539889-8C64DF0F-0394-40F4-8FBA-F3094DDF0487 Q28554352-60E2A635-191A-4313-BB83-DC791E4F2B62 Q28660034-8D64A2DF-762D-4BAD-BE01-459F44D0DCCB Q33610280-9C8BEF09-450D-410B-B50D-27E5DE3C40B5 Q33873538-63024690-7E4D-4DF8-9689-77015555F74C Q33931800-6B819318-759A-4389-AE9A-258160665333 Q34159466-0F59847D-5EB5-4A3C-803B-CBCA15987D87 Q34270396-CAA6E7FA-7E4C-4412-A32B-78811AD82EDC Q34281340-8DDC41F9-47D3-4580-A25A-009EEF637D56 Q35007339-B334D44E-F0D8-42F1-9575-CCA0C0191018 Q35063626-9A8213C0-DC41-4010-8CA8-C64D4D30C67F Q35122783-83C2D1E7-2233-40DF-9872-47F2ADA114FD Q35440147-510C3584-AB8B-4E26-82B0-C4768DB8AB1A Q35606725-6E106C46-C9BD-4627-8E89-087A71ECFD9C Q35726734-BEDCDCD2-0EBB-4CF6-A913-A06944879566 Q35782918-92A763F5-B1D5-42CC-BCAA-4BE0CCE7EB04 Q35814647-EAC31E07-50FD-455C-9DA7-09E60059E396 Q35830682-44ACE277-24DB-4901-89B4-936C30612DA9 Q35911433-428C1486-F63F-4D17-8B70-0721E71007EB Q35924760-B181857C-5024-4838-A86F-B7CA4C2A14CA Q35996523-1BB30C29-B86A-4071-8C22-6D1A8C8974DA Q36565777-FF8C71CA-1DED-487D-9DD2-BED97BA26940 Q36590733-C83128C2-31DA-4484-9ABE-C08BEFC727C3 Q36687603-4E14E84F-8B6B-456B-8659-3957B69F5A72 Q36694953-2F8A3249-DD21-4028-866D-FD4840C4F090 Q36728173-8EDC9408-6E51-4F36-8FC4-08D3B5994B3B Q37003023-4AC23AEE-B703-4F5E-AD82-3BF45219FE18 Q37133136-4842898C-6842-4DFA-A906-A54AD8CDB443 Q38790617-7F26CD8A-FBFF-44CB-B108-272563E0B4CB Q38812005-84A15A6B-CBC8-445F-B9AF-729D501909F1 Q38917051-7248982B-E91C-4B08-A485-B76A8332CB62 Q39001808-4E669F2D-EAF8-402E-A9A2-F005B1795184 Q40066321-E8926742-C31F-4CD6-9E01-1D2CCF08D784 Q42240673-82F03550-9264-4654-A8D4-129C04409CF9 Q42408563-69FAA013-2E1C-4371-BAC1-C00E03A1DF49

P2860

Morphine enhances Tat-induced activation in murine microglia.

http://www.wikidata.org/entity/Q35063629

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Morphine enhances Tat-induced activation in murine microglia.

@ast

Morphine enhances Tat-induced activation in murine microglia.

@en

type

label

Morphine enhances Tat-induced activation in murine microglia.

@ast

Morphine enhances Tat-induced activation in murine microglia.

@en

prefLabel

Morphine enhances Tat-induced activation in murine microglia.

@ast

Morphine enhances Tat-induced activation in murine microglia.

@en

P1433

Q35063629-15686A34-BBD7-4D70-A397-98E460589D39

P1476

Q35063629-19C07A17-4918-4A7A-A88B-A81FE0278954

P2093

Q35063629-47CC6B52-CD38-4D6E-B8D5-64891EE8F486

Q35063629-7E073505-2329-43C5-B649-1EBA0FA3BE00

Q35063629-7EA5A553-B761-4658-81DE-5FA5D55D3329

Q35063629-C234AC78-7407-4397-9F32-DB754CA5ED8E

Q35063629-DD61D5B3-5D0D-457B-B702-183ED577C867

Q35063629-E85A1E8F-947F-4172-A6D1-57C54B87576A

Q35063629-F318752C-2708-4655-96F7-A6CD38A3900A

Q35063629-FC6825A0-D3F2-4420-80F0-DAFD351754FB

P2860

Q35063629-01008E56-8CCA-47D8-A030-3FA49D9C1101

Q35063629-014DE42E-61B3-4C88-B089-56F893CA3442

Q35063629-08DF1297-542C-4441-9684-783E44C95E99

Q35063629-0AB5FA9F-F022-4A73-9C8F-8C91FACDE342

Q35063629-3821A7A5-A120-4926-BC55-F4429A856AE2

Q35063629-3E9DB002-1857-45AB-ADF8-43408C40CFE2

Q35063629-42825205-508B-4A1C-837C-1ED0EB020366

Q35063629-48166DA0-E6C1-4C3E-B6AF-75A29154C990

Q35063629-52577A91-441E-468F-B092-72BE8AD08E39

Q35063629-58C65986-1E71-4DCA-99E7-33FB619EFD95

P2888

Q35063629-06DB274D-C687-4037-A882-B5B539F051D3

P304

Q35063629-D1B15720-403D-44A2-8A9C-9B1D5A6929DF

P31

Q35063629-CD9E07C1-2234-4A8D-8C14-62A6C6F15439

P356

Q35063629-D1D6C859-F974-48CB-AD81-04B593467B2C

P433

Q35063629-6ADFB332-98E5-4891-A4C2-5D3548A738C8

P478

Q35063629-578C86A1-8315-4C8C-9C72-7F03BE38F5A2

P50

Q35063629-0E159AFB-DCA4-43A1-9DD4-7F2323DDD3EE

P577

Q35063629-0C38DF62-4BD1-4015-952F-7CDCB419C1C1

P5875

Q35063629-92B5D562-8696-46F5-87D9-094F110BC1F2

P6179

Q35063629-9ED978FB-8F55-4815-9173-8205EC55359E

P698

Q35063629-ACFDB7E7-21DC-46A9-9A3A-F0F4E7044CE4

P921

Q35063629-1CECCD69-E781-4B91-8B61-89124656BCF8

P932

Q35063629-9D0A9AEB-593E-4225-928C-9C14C8AE8F7B

P356

13550280902913628

P1433

Journal of NeuroVirology

P1476

Morphine enhances Tat-induced activation in murine microglia

@en

P2093

Anil Kumar

http://www.w3.org/2001/XMLSchema#string

Crystal Bethel-Brown

http://www.w3.org/2001/XMLSchema#string

Honghong Yao

http://www.w3.org/2001/XMLSchema#string

Navneet K Dhillon

http://www.w3.org/2001/XMLSchema#string

Peng Fuwang

http://www.w3.org/2001/XMLSchema#string

Rachel Williams

http://www.w3.org/2001/XMLSchema#string

Ramakrishna Hegde

http://www.w3.org/2001/XMLSchema#string

Sirosh M Bokhari

http://www.w3.org/2001/XMLSchema#string

P2860

Role of microglia in central nervous system infections

HIV-1 associated dementia: symptoms and causes

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

ATP mediates rapid microglial response to local brain injury in vivo

Microglia as mediators of inflammatory and degenerative diseases.

Microglia as a source and target of cytokines.

CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis.

Evolving paradigms in the pathogenesis of HIV-1-associated dementia.

Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.

An artificial three-dimensional matrix promotes ramification in the microglial cell-line, BV-2.

P2888

13550280902913628

P304

219-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13550280902913628

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24446411

http://www.w3.org/2001/XMLSchema#string

P6179

1021175099

http://www.w3.org/2001/XMLSchema#string

P698

19462331

http://www.w3.org/2001/XMLSchema#string

P921

P932

3121575

http://www.w3.org/2001/XMLSchema#string